1. Home
  2. HUDI vs XLO Comparison

HUDI vs XLO Comparison

Compare HUDI & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUDI
  • XLO
  • Stock Information
  • Founded
  • HUDI 1998
  • XLO 2016
  • Country
  • HUDI China
  • XLO United States
  • Employees
  • HUDI N/A
  • XLO N/A
  • Industry
  • HUDI Steel/Iron Ore
  • XLO Biotechnology: Pharmaceutical Preparations
  • Sector
  • HUDI Industrials
  • XLO Health Care
  • Exchange
  • HUDI Nasdaq
  • XLO Nasdaq
  • Market Cap
  • HUDI 39.2M
  • XLO 36.2M
  • IPO Year
  • HUDI 2021
  • XLO 2021
  • Fundamental
  • Price
  • HUDI $2.11
  • XLO $0.81
  • Analyst Decision
  • HUDI
  • XLO
  • Analyst Count
  • HUDI 0
  • XLO 0
  • Target Price
  • HUDI N/A
  • XLO N/A
  • AVG Volume (30 Days)
  • HUDI 62.9K
  • XLO 98.9K
  • Earning Date
  • HUDI 08-06-2024
  • XLO 11-07-2024
  • Dividend Yield
  • HUDI N/A
  • XLO N/A
  • EPS Growth
  • HUDI N/A
  • XLO N/A
  • EPS
  • HUDI 0.18
  • XLO N/A
  • Revenue
  • HUDI $83,462,634.00
  • XLO $2,357,000.00
  • Revenue This Year
  • HUDI N/A
  • XLO N/A
  • Revenue Next Year
  • HUDI N/A
  • XLO $383.35
  • P/E Ratio
  • HUDI $12.65
  • XLO N/A
  • Revenue Growth
  • HUDI 7.65
  • XLO N/A
  • 52 Week Low
  • HUDI $1.88
  • XLO $0.49
  • 52 Week High
  • HUDI $4.25
  • XLO $2.89
  • Technical
  • Relative Strength Index (RSI)
  • HUDI 42.20
  • XLO 52.99
  • Support Level
  • HUDI $2.15
  • XLO $0.73
  • Resistance Level
  • HUDI $2.33
  • XLO $0.84
  • Average True Range (ATR)
  • HUDI 0.25
  • XLO 0.07
  • MACD
  • HUDI -0.05
  • XLO 0.01
  • Stochastic Oscillator
  • HUDI 16.64
  • XLO 70.65

About HUDI Huadi International Group Co. Ltd.

Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Products are exported to the United States, Mexico, Thailand, Australia, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

Share on Social Networks: